Bioqual Inc
OTC:BIOQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PION Group AB
STO:PION B
|
SE |
Bioqual Inc
Cash from Operating Activities
Bioqual Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bioqual Inc
OTC:BIOQ
|
Cash from Operating Activities
$2.9m
|
CAGR 3-Years
111%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
2%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Operating Activities
$19B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
2%
|
CAGR 10-Years
10%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Operating Activities
$10B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Operating Activities
$10B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Operating Activities
$3.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Operating Activities
$5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
|
Bioqual Inc
Glance View
Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The firm also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. The In vitro services include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation and other cell-based assays. The firm provides its services to the federal government, universities and the life science and pharmaceutical industries.
See Also
What is Bioqual Inc's Cash from Operating Activities?
Cash from Operating Activities
2.9m
USD
Based on the financial report for May 31, 2025, Bioqual Inc's Cash from Operating Activities amounts to 2.9m USD.
What is Bioqual Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
2%
Over the last year, the Cash from Operating Activities growth was -69%. The average annual Cash from Operating Activities growth rates for Bioqual Inc have been 111% over the past three years , -6% over the past five years , and 2% over the past ten years .
